rs201713027
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_001184880.2(PCDH19):āc.769G>Cā(p.Val257Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000591 in 1,211,112 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 246 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH19 | NM_001184880.2 | c.769G>C | p.Val257Leu | missense_variant | 1/6 | ENST00000373034.8 | NP_001171809.1 | |
PCDH19 | NM_001105243.2 | c.769G>C | p.Val257Leu | missense_variant | 1/5 | NP_001098713.1 | ||
PCDH19 | NM_020766.3 | c.769G>C | p.Val257Leu | missense_variant | 1/5 | NP_065817.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH19 | ENST00000373034.8 | c.769G>C | p.Val257Leu | missense_variant | 1/6 | 1 | NM_001184880.2 | ENSP00000362125 | A1 | |
PCDH19 | ENST00000255531.8 | c.769G>C | p.Val257Leu | missense_variant | 1/5 | 1 | ENSP00000255531 | P5 | ||
PCDH19 | ENST00000420881.6 | c.769G>C | p.Val257Leu | missense_variant | 1/5 | 1 | ENSP00000400327 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000602 AC: 68AN: 112877Hom.: 0 Cov.: 24 AF XY: 0.000371 AC XY: 13AN XY: 35037
GnomAD3 exomes AF: 0.000567 AC: 103AN: 181777Hom.: 0 AF XY: 0.000533 AC XY: 36AN XY: 67601
GnomAD4 exome AF: 0.000590 AC: 648AN: 1098181Hom.: 0 Cov.: 33 AF XY: 0.000641 AC XY: 233AN XY: 363537
GnomAD4 genome AF: 0.000602 AC: 68AN: 112931Hom.: 0 Cov.: 24 AF XY: 0.000370 AC XY: 13AN XY: 35101
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | PCDH19: PP2, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2019 | This variant is associated with the following publications: (PMID: 23334464) - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 23, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 28, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 12, 2017 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
PCDH19-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 22, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Developmental and epileptic encephalopathy, 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 08, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at